<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Scarce data are available about safety and efficacy of cetuximab in elderly <z:e sem="disease" ids="C0948380" disease_type="Neoplastic Process" abbrv="">metastatic colorectal cancer</z:e> (mCRC) patients </plain></SENT>
<SENT sid="1" pm="."><plain>PATIENTS AND METHODS: We retrospectively analysed 54 irinotecan-refractory mCRC patients agedâ‰¥70 years treated with cetuximab plus irinotecan and evaluated clinical outcome according to KRAS and BRAF mutational status </plain></SENT>
<SENT sid="2" pm="."><plain>RESULTS: Median age was 73 years (70-82) </plain></SENT>
<SENT sid="3" pm="."><plain>Main grade 3-4 toxicities were <z:hpo ids='HP_0000988'>skin rash</z:hpo> (15%), <z:hpo ids='HP_0002014'>diarrhea</z:hpo> (19%) and <z:hpo ids='HP_0001875'>neutropenia</z:hpo> (13%) </plain></SENT>
<SENT sid="4" pm="."><plain>Irinotecan dose reduction was necessary in 39% of patients </plain></SENT>
<SENT sid="5" pm="."><plain>Fifty-two (96%) patients were analysed for KRAS and BRAF status </plain></SENT>
<SENT sid="6" pm="."><plain>The 29 KRAS <z:mp ids='MP_0002169'>wild-type</z:mp> patients achieved better RR (31% vs 4%; p=0.030) and median PFS (4.21 months vs 3.95 months; p=0.034; HR: 0.50, 95% CI: 0.27-0.95) when compared with KRAS mutated ones </plain></SENT>
<SENT sid="7" pm="."><plain>RR (41% vs 3%; p=0.001) and mPFS (4.57 months vs 3.78 months, p=0.001; HR: 0.35, 95% CI: 0.19-0.66) were significantly higher among the 22 KRAS and BRAF <z:mp ids='MP_0002169'>wild-type</z:mp> patients compared to the 30 KRAS or BRAF mutated ones </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSION: Cetuximab plus irinotecan has a favourable safety profile in elderly mCRC patients, but a reduced dose of irinotecan should be considered </plain></SENT>
<SENT sid="9" pm="."><plain>Such a combination can be a useful option for elderly KRAS and BRAF <z:mp ids='MP_0002169'>wild-type</z:mp> patients </plain></SENT>
</text></document>